Dr. Steven Powell, MD
Claim this profileSanford Cancer Center
Area of expertise
Cancer
Steven Powell, MD has run 4 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Steven Powell, MD has run 4 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Sanford Cancer Center
Sanford Health
Clinical Trials Steven Powell, MD is currently running
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting
1 award
Phase 2
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting
1 award
Phase 2
9 criteria
More about Steven Powell, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Steven Powell, MD has experience with
- Nivolumab
- Pembrolizumab
- BMS-986218
- Ipilimumab
- STI-6643
- Atezolizumab And PHESGO
Breakdown of trials Steven Powell, MD has run
Cancer
Solid Tumors
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Powell, MD specialize in?
Steven Powell, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Steven Powell, MD currently recruiting for clinical trials?
Yes, Steven Powell, MD is currently recruiting for 3 clinical trials in Sioux Falls South Dakota. If you're interested in participating, you should apply.
Are there any treatments that Steven Powell, MD has studied deeply?
Yes, Steven Powell, MD has studied treatments such as Nivolumab, Pembrolizumab, BMS-986218.
What is the best way to schedule an appointment with Steven Powell, MD?
Apply for one of the trials that Steven Powell, MD is conducting.
What is the office address of Steven Powell, MD?
The office of Steven Powell, MD is located at: Sanford Cancer Center, Sioux Falls, South Dakota 57104 United States. This is the address for their practice at the Sanford Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.